EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

FTO-mediated m6A demethylation of CSF3 suppresses NETosis via downregulation of RLN2 expression in colorectal cancer

Junfeng Xu, Jie Zhang, Ruoran Li, Shengxin Chen, Changwei Duan, Xianzong Ma, Xuexin Wang, Xinyan Liu, Lingyun Gu, Ke Meng, Mingyang Li

Cell Biology and Toxicology · 2026

DOI: 10.1007/s10565-025-10120-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology and Toxicology, 2026. Verfasst von Junfeng Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Gastroenterology, Chinese PLA General Hospital, Beijing, 100853, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Extracellular Traps, Peptide Hormones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CSF3 exerts a significant function in the progression of colorectal cancer (CRC). N6-methyladenosine (m6A) modification is now considered the main driving factor of RNA influence for maintaining homeostasis in cancer cells. Nevertheless, how m6A mediates the role of CSF3 and its influence in pathogenesis of CRC is still elusive. After neutrophil isolation from bone marrow, the purity and survival rate of neutrophils were assessed. Azoxymethane (AOM)/Dextran Sodium Sulfate (DSS) was employed to construct the CRC mice model. Both loss-of-function and gain-of-function experiments were conducted to explore the influence of CSF3 on NETosis and tumorigenesis of CRC in vitro and in vivo. The purity and survival rate of neutrophils were 88.07% and 94.84%, respectively. Overexpression of CSF3 (oe-CSF3) markedly enhanced NETosis, while CSF3 knockdown (sh-CSF3) suppressed it. Intriguingly, CSF3 expression positively correlated with relaxin-2 (RLN2) levels in CRC cells, and RLN2 supplementation rescued tumorigenesis and NETosis after sh-CSF3 treatment. Mechanistically, fat mass and obesity-associated protein (FTO)-mediated m6A demethylation of CSF3 mRNA suppressed CRC tumorigenesis in vivo. CSF3 upregulation counteracted the tumor-suppressive effects of FTO overexpression, restoring NETosis and tumor growth. Consistent with this, FTO overexpression in CRC mice alleviated disease severity, as evidenced by improved body weight, reduced tumor burden, and diminished NETosis. Collectively, our findings establish a novel regulatory axis in which FTO-dependent m6A demethylation of CSF3 suppresses NETosis by inhibiting RLN2 expression, offering new insights into therapeutic targeting of the m6A-CSF3-RLN2 pathway in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAlpha-Ketoglutarate-Dependent Dioxygenase FTOExtracellular TrapsPeptide HormonesAdenosineAnimalsHumansMiceNeutrophilsDown-RegulationMaleDemethylationCell Line, TumorMice, Inbred C57BLGene Expression Regulation, NeoplasticCarcinogenesis

Stichwörter der Autor:innen

CSF3Colorectal cancerFTON6-methyladenosineNETosisRLN2

Substanzen

Alpha-Ketoglutarate-Dependent Dioxygenase FTON-methyladenosinePeptide HormonesAdenosineFTO protein, mouseFTO protein, human

Autor:innen und Institutionen

  • Senior Department of Gastroenterology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Department of Gastroenterology, The Seventh Medical Center of Chinese, PLA General Hospital, Beijing, 100700, China.
  • Graduate School, Chinese PLA General Hospital, Beijing, 100853, China.
  • Department of Chinese Medicine, Sixth Medical Center, Chinese PLA General Hospital, Beijing, 100048, China. gulingyun38@sina.com.
  • Senior Department of Gastroenterology, Chinese PLA General Hospital, Beijing, 100853, China. mengke301@126.com.
  • Senior Department of Gastroenterology, Chinese PLA General Hospital, Beijing, 100853, China. mingyangli_pla@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xu, J., Zhang, J., Li, R., Chen, S., Duan, C., Ma, X., Wang, X., Liu, X., Gu, L., Meng, K., & Li, M. (2026). FTO-mediated m6A demethylation of CSF3 suppresses NETosis via downregulation of RLN2 expression in colorectal cancer. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-025-10120-9

Vancouver

Xu J, Zhang J, Li R, Chen S, Duan C, Ma X, et al. FTO-mediated m6A demethylation of CSF3 suppresses NETosis via downregulation of RLN2 expression in colorectal cancer. Cell Biology and Toxicology. 2026. doi:10.1007/s10565-025-10120-9

BibTeX
@article{Xu2026,
  author = {Xu, Junfeng and Zhang, Jie and Li, Ruoran and Chen, Shengxin and Duan, Changwei and Ma, Xianzong and Wang, Xuexin and Liu, Xinyan and Gu, Lingyun and Meng, Ke and Li, Mingyang},
  title = {FTO-mediated m6A demethylation of CSF3 suppresses NETosis via downregulation of RLN2 expression in colorectal cancer},
  journal = {Cell Biology and Toxicology},
  year = {2026},
  doi = {10.1007/s10565-025-10120-9}
}
Kostenlos starten →